Freenome, Inc. FRNM

No annual revenue total was found in Freenome, Inc.'s SEC filings.

Freenome, Inc. (FRNM) files with the SEC under industry code 8071, Services-Medical Laboratories.

Revenue
—
Net income (TTM)
$-762,626
Operating cash flow (TTM)
$-907,040
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
8.91M
+0.0% vs prior year
Net cash
—
Operating margin
—

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
FRNM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brisbane, CA
SEC filer status
, Emerging growth company
SEC CIK
2017526
Former names
Perceptive Capital Solutions Corp (until Jul 15, 2026)

Other Services-Medical Laboratories companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
Operating income
-$3.0M
Net income
$837,468
Operating cash flow
-$864,653
Total assets
$92.8M
Total liabilities
$5.7M
Stockholders' equity
-$4.8M
Cash and investments
$865,031

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Oct 20, 2026 Oct 20, 2026
8-K/A Amended current report
Acquisition or sale of assets
Aug 13, 2026 Jul 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 27, 2026 Jul 27, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Jul 24, 2026 Jul 20, 2026
8-K Current report
Shareholder vote results
Jul 15, 2026 Jul 15, 2026
10-Q Quarterly report Jul 15, 2026 Jun 30, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.